Patents Assigned to MacuCLEAR, Inc.
  • Therapeutic formulation and methods of treatment
    Patent number: 9694010
    Abstract: The present disclosure relates pharmaceutical formulations comprising hydralazine in the treatment of eye diseases and conditions with the formulations. The present disclosure also related to methods of preparing the pharmaceutical formulations.
    Type: Grant
    Filed: February 8, 2016
    Date of Patent: July 4, 2017
    Assignee: MacuCLEAR, Inc.
    Inventors: Pamela A. Lewis, William H. Woller
  • Therapeutic formulation and methods of treatment
    Patent number: 9254287
    Abstract: The present disclosure relates pharmaceutical formulations comprising hydralazine in the treatment of eye diseases and conditions with the formulations. The present disclosure also related to methods of preparing the pharmaceutical formulations.
    Type: Grant
    Filed: June 6, 2013
    Date of Patent: February 9, 2016
    Assignee: MacuCLEAR, Inc.
    Inventors: Pamela A. Lewis, William H. Woller